The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 12: Oral Presentations of Selected Abstracts II
Session Chairs: Judith Trotman (Australia) and Ranjana Advani (USA)
Development of novel IRAK1 inhibitors for treatment of WM X. Liu (USA)
CANOMAD: Clinical, Biological, Electrophysiological and Treatment Analysis M. LeCann (France)
Ibrutinib Therapy in WM: Outcomes Outside a Clinical Trial J. Abeykoon (USA)
Phase II Study of Idelalisib and Obinutuzumab in relapsed/refractory WM C.Tomowiak (France)
Phase II Study of Bendamustine, Rituximab, Bortezomib in relapsed/refractory WM G. Benevolo (Italy)